UW Innovations in Malignancy Personalized Advanced Cell Therapies (UW-IMPACT)
At a Glance
Two incurable cancers, prostate cancer and pediatric neuroblastoma (a cancer often found in the adrenal glands) have high incidence rates in Wisconsin. This study will attempt to treat these cancers with an exciting new therapy approach using B-cells.
The Challenge
Prostate cancer and neuroblastoma have high incidence rates in adults and children, respectively, in Wisconsin. To address this, leaders in cancer immunotherapy and basic and translational cell technology are developing transformative innovations in the use of a patient’s own B-cells to treat cancer by initiating an anti-tumor immune response. This is the first study using B-cell therapy—discovered at UW–Madison—to treat cancer in humans.
Project Goals
This project aims to produce personalized cell therapies for otherwise incurable adult prostate and pediatric neuroblastoma malignancies. These discoveries may provide a new therapeutic approach to treating cancer. By translating these discoveries into treatments, the team hopes to improve cancer outcomes for the young and old in Wisconsin and beyond.
More about personalized cancer therapy